Cannabidiol Reduces Intestinal Inflammation and Hypermotility

Evidence suggests that CBD is effective for intestinal issues such as IBS, IBD, ulcerative colitis and Crohn’s disease. 

Scientists are continually discovering new benefits for cannabidiol, or CBD, a natural compound derived from the hemp plant.  In research, CBD has been said to possess great inflammatory properties.  Anecdotal evidence suggests that CBD is effective for intestinal issues such as IBS, IBD, ulcerative colitis and Crohn’s disease.

Researchers at the University of Naples Federico II, in Italy, conducted a study to investigate the effect of CBD on intestinal inflammation and hypermotility in mice.  The mice were first treated with dinitrobenzenesulfonic acid (DNBS) to induce both intestinal inflammation and hypermotility.  After administering CBD, researchers noted that the damage caused by the DNBS, measured by inflammation and hypermotility levels, decreased.  Their findings sustained the claims that CBD could reduce injury and inflammation to the intestines, as well as, aid in hypermotility.

We encourage further independent research and clinical trials involving cannabidiol.  For those suffering from intestinal complications, CBD may offer a natural, well-tolerated option to help soothe an already irritated system.

To read more on the aforementioned study, click here.

CBD to Treat GI Disorders

When you combine the CBD’s anti-inflammatory properties with its unique ability to regulate the body’s endocannabinoid system, it comes as no surprise that many people are finding CBD to be an effective treatment to many different types of GI disorders.

Cannabidiol, or CBD, has been proven to be an effective anti-inflammatory.  Many gastrointestinal (GI) disorders are accompanied by inflammation of the stomach, intestines and/or colon.  When you combine the CBD’s anti-inflammatory properties with its unique ability to regulate the body’s endocannabinoid system, it comes as no surprise that many people are finding CBD to be an effective treatment to many different types of GI disorders.  Scientists worldwide are researching the effects CBD has on the gastrointestinal system.

Researchers at the Department of Experimental Pharmacology at the University of Naples, Italy, conducted a study to assess the effect of cannabidiol on intestinal inflammation.  Studying both humans suffering from ulcerative colitis (UC) and mice, they observed that “CBD targets enteric reactive gliosis, counteracts the inflammatory environment induced by LPS in mice and in human colonic cultures derived from UC patients.” The research group concluded that “CBD is a new therapeutic strategy to treat inflammatory bowel diseases.”  Although more research is needed to clarify issues such as dosage and long-term tolerability, current evidence shows CBD is an effective therapy for many GI disorders.
 
Current treatments for GI disorders include extremely limited diets, pharmaceuticals and even surgery.  Those who suffer from GI disorders often experience a diminished quality of life due to the embarrassing side effects GI disorders can pose.  Finding an effective, natural therapy option, with little to no side effects, such as CBD, would be a major breakthrough for those currently suffering from gastrointestinal disorders.

To learn more about this study, click here.